Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 24;22(1):97-105.
doi: 10.1515/sjpain-2021-0079. Print 2022 Jan 27.

Ketamine therapy for chronic pain in The Netherlands: a nationwide survey

Thomas J P Mangnus  1 , Krishna D Bharwani  1 , Dirk L Stronks  1 , Maaike Dirckx  1 , Frank J P M Huygen  1
Affiliations
Free article

Ketamine therapy for chronic pain in The Netherlands: a nationwide survey

Thomas J P Mangnus et al. Scand J Pain. .
Free article

Abstract

Objectives: Ketamine is used to treat chronic refractory pain. However, there are no scientific guidelines for ketamine use in the Netherlands. The aim of this survey was to provide an overview of the use of ketamine for chronic pain in the Netherlands.

Methods: All pain clinics in the Netherlands were contacted. A digital survey, available from June 2019 to January 2020, was sent to 68 pain clinics. The survey was completed by one pain physician as a representative of the entire pain department. The survey included questions about ketamine treatment indications, administration, dose, duration, treatment repetition and the inpatient or outpatient setting.

Results: The survey was completed by 51 pain clinics (75.0%). Thirty-one clinics used ketamine for chronic pain treatment. The most common indication was Complex Regional Pain Syndrome (83.9%). Pain clinics administered ketamine via intravenous infusions (96.8%), iontophoresis (61.3%), subcutaneous (3.2%) or oral administration (3.2%). Intravenous ketamine treatment was offered in an inpatient setting in 14 pain clinics, in both an inpatient and outpatient setting in 11 pain clinics and in six pain clinics in an outpatient setting. In the outpatient setting, the median starting dose was 5 mg/h (IQR=17.5-5). The median maximum dose was 27.5 mg/h (IQR=100-11.9). The median infusion duration was 6 h (IQR=8-4). In the inpatient setting, the median starting dose was 5 mg/h (IQR=5-1.5) and the median maximum dose was 25 mg/h (IQR=25-14). Patients were admitted to hospital for a median of 4 days (IQR=5-1).

Conclusions: The results of this Dutch nationwide survey study show that there are heterogeneous treatment protocols with different indications, treatment setting and dosing regimen for the treatment of chronic pain with ketamine. This study encourages the formulation of a broader consensus and the development of evidence based guidelines for ketamine treatment.

Keywords: chronic pain; inpatient/outpatient setting; ketamine; treatment indications.

PubMed Disclaimer

References

    1. Breivik, H, Collett, B, Ventafridda, V, Cohen, R, Gallacher, D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287–333. https://doi.org/10.1016/j.ejpain.2005.06.009 . - DOI
    1. Treede, RD, Rief, W, Barke, A, Aziz, Q, Bennett, MI, Benoliel, R, et al.. Chronic pain as a symptom or a disease: the IASP classification of chronic pain for the international classification of diseases (ICD-11). Pain 2019;160:19–27. https://doi.org/10.1097/j.pain.0000000000001384 . - DOI
    1. Maniadakis, N, Gray, A. The economic burden of back pain in the UK. Pain 2000;84:95–103. https://doi.org/10.1016/s0304-3959(99)00187-6 . - DOI
    1. Bekkering, GE, Bala, MM, Reid, K, Kellen, E, Harker, J, Riemsma, R, et al.. Epidemiology of chronic pain and its treatment in The Netherlands. Neth J Med 2011;69:141–53.
    1. Elliott, AM, Smith, BH, Penny, KI, Smith, WC, Chambers, WA. The epidemiology of chronic pain in the community. Lancet 1999;354:1248–52. https://doi.org/10.1016/s0140-6736(99)03057-3 . - DOI

LinkOut - more resources